Karen Dorso

2.3k total citations
18 papers, 729 citations indexed

About

Karen Dorso is a scholar working on Pharmacology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Karen Dorso has authored 18 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 10 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Karen Dorso's work include Microbial Natural Products and Biosynthesis (11 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Karen Dorso is often cited by papers focused on Microbial Natural Products and Biosynthesis (11 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Karen Dorso collaborates with scholars based in United States and Spain. Karen Dorso's co-authors include Sheo B. Singh, Francisca Vicente, Mary Motyl, Jun Wang, Kithsiri Herath, Srinivas Kodali, Hiranthi Jayasuriya, Deborah L. Zink, Doris Cully and David Bramhill and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karen Dorso

18 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Dorso United States 17 367 333 191 180 108 18 729
Maulik Thaker Canada 15 549 1.5× 582 1.7× 182 1.0× 208 1.2× 116 1.1× 15 1.0k
Luciano Gastaldo Italy 16 445 1.2× 597 1.8× 161 0.8× 65 0.4× 106 1.0× 24 941
Srinivas Kodali United States 9 206 0.6× 271 0.8× 162 0.8× 81 0.5× 126 1.2× 12 618
Catherine Leimkuhler United States 13 397 1.1× 625 1.9× 438 2.3× 96 0.5× 153 1.4× 16 972
Gianfranco De Pascale Canada 13 308 0.8× 483 1.5× 167 0.9× 509 2.8× 265 2.5× 20 1.1k
Hideaki Ui Japan 20 362 1.0× 552 1.7× 295 1.5× 74 0.4× 58 0.5× 36 1.1k
Dominik Pistorius Germany 19 396 1.1× 562 1.7× 185 1.0× 70 0.4× 51 0.5× 27 846
Andrew P. Riley United States 11 171 0.5× 466 1.4× 243 1.3× 268 1.5× 96 0.9× 21 980
Beth A. Rasmussen United States 17 249 0.7× 512 1.5× 234 1.2× 511 2.8× 153 1.4× 22 1.1k
Philipp Krastel Switzerland 19 511 1.4× 645 1.9× 235 1.2× 67 0.4× 141 1.3× 32 1.1k

Countries citing papers authored by Karen Dorso

Since Specialization
Citations

This map shows the geographic impact of Karen Dorso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Dorso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Dorso more than expected).

Fields of papers citing papers by Karen Dorso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Dorso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Dorso. The network helps show where Karen Dorso may publish in the future.

Co-authorship network of co-authors of Karen Dorso

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Dorso. A scholar is included among the top collaborators of Karen Dorso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Dorso. Karen Dorso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Singh, Sheo B., Michael Goetz, Scott K. Smith, et al.. (2012). Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities. Bioorganic & Medicinal Chemistry Letters. 22(23). 7127–7130. 33 indexed citations
2.
Zhang, Chaowei, John G. Ondeyka, Michael Lester, et al.. (2010). Isolation, structure and biological activities of platencin A2–A4 from Streptomyces platensis. Bioorganic & Medicinal Chemistry. 18(7). 2602–2610. 21 indexed citations
3.
Goetz, Michael, Chaowei Zhang, Deborah L. Zink, et al.. (2010). Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profiling. The Journal of Antibiotics. 63(8). 512–518. 16 indexed citations
4.
Huber, Joann, Robert G. K. Donald, Sang Ho Lee, et al.. (2009). Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus. Chemistry & Biology. 16(8). 837–848. 75 indexed citations
5.
Shen, Hong C., Fa‐Xiang Ding, Sheo B. Singh, et al.. (2009). Synthesis and biological evaluation of platensimycin analogs. Bioorganic & Medicinal Chemistry Letters. 19(6). 1623–1627. 51 indexed citations
6.
Zhang, Chaowei, John G. Ondeyka, Deborah L. Zink, et al.. (2009). Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4. The Journal of Antibiotics. 62(2). 55–61. 24 indexed citations
7.
Zhang, Chaowei, James Occi, Prakash Masurekar, et al.. (2008). Isolation, Structure, and Antibacterial Activity of Philipimycin, A Thiazolyl Peptide Discovered from Actinoplanes philippinensis MA7347. Journal of the American Chemical Society. 130(36). 12102–12110. 48 indexed citations
8.
Zhang, Chaowei, John G. Ondeyka, Deborah L. Zink, et al.. (2008). Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy. Bioorganic & Medicinal Chemistry. 17(6). 2162–2166. 25 indexed citations
9.
Singh, Sheo B., Deborah L. Zink, Karen Dorso, et al.. (2008). Isolation, Structure, and Antibacterial Activities of Lucensimycins D−G, Discovered from Streptomyces lucensis MA7349 Using an Antisense Strategy. Journal of Natural Products. 72(3). 345–352. 28 indexed citations
10.
Zhang, Chaowei, John G. Ondeyka, Deborah L. Zink, et al.. (2008). Isolation, Structure, and Antibacterial Activity of Phaeosphenone from a Phaeosphaeria sp. Discovered by Antisense Strategy. Journal of Natural Products. 71(7). 1304–1307. 26 indexed citations
11.
Singh, Sheo B., James Occi, Hiranthi Jayasuriya, et al.. (2007). Antibacterial Evaluations of Thiazomycin. The Journal of Antibiotics. 60(9). 565–571. 37 indexed citations
12.
Motyl, Mary, Karen Dorso, J. Barrett, & R.A. Giacobbe. (2005). Basic Microbiological Techniques Used in Antibacterial Drug Discovery. Current Protocols in Pharmacology. 31(1). Unit13A.3–Unit13A.3. 37 indexed citations
13.
Parish, Craig A., Joann Huber, Antonio González, et al.. (2004). A New Ene-triyne Antibiotic from the Fungus Baeospora myosura. Journal of Natural Products. 67(11). 1900–1902. 20 indexed citations
14.
Wang, Jun, Andrew Galgoci, Srinivas Kodali, et al.. (2003). Discovery of a Small Molecule That Inhibits Cell Division by Blocking FtsZ, a Novel Therapeutic Target of Antibiotics. Journal of Biological Chemistry. 278(45). 44424–44428. 162 indexed citations
15.
Wilkening, Robert R., Ronald W. Ratcliffe, Kenneth J. Wildonger, et al.. (1999). Synthesis and activity of 2-(sulfonamido)methyl-carbapenems: Discovery of a novel, anti-MRSA 1,8-naphthosultam pharmacophore. Bioorganic & Medicinal Chemistry Letters. 9(5). 673–678. 21 indexed citations
16.
Ratcliffe, Ronald W., Robert R. Wilkening, Kenneth J. Wildonger, et al.. (1999). Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: Discovery of L-786,392. Bioorganic & Medicinal Chemistry Letters. 9(5). 679–684. 22 indexed citations
18.
Waddell, Sherman T., Ronald W. Ratcliffe, Kenneth J. Wildonger, et al.. (1995). Benzothiazolylthio carbapenems: potent anti-MRSA agents. Bioorganic & Medicinal Chemistry Letters. 5(13). 1427–1432. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026